DNTH vs QCOM · rev $6.2M vs P/E 16, rev $44.28B
Dianthus Therapeutics Inc. (DNTH) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
DNTH currently screens at market cap $4.40B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the DNTH and QCOM stock pages for the full models.
Not investment advice.